Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $8.21 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,095 shares of the medical research company's stock after selling 2,419 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS's holdings in Agilent Technologies were worth $8,208,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CKW Financial Group grew its holdings in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. lifted its holdings in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares in the last quarter. RPg Family Wealth Advisory LLC acquired a new position in Agilent Technologies in the third quarter valued at about $38,000. Hanson & Doremus Investment Management increased its holdings in shares of Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after acquiring an additional 105 shares in the last quarter. Finally, OFI Invest Asset Management acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $37,000.

Remove Ads

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares of the company's stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Sanford C. Bernstein lowered their target price on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a research note on Tuesday, November 26th. JPMorgan Chase & Co. dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Tuesday, November 26th. Robert W. Baird reduced their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Barclays raised Agilent Technologies from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Finally, Citigroup lifted their target price on Agilent Technologies to $165.00 and gave the company a "buy" rating in a research report on Thursday, December 19th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $146.15.

Agilent Technologies Stock Performance

Shares of A traded down $0.82 during midday trading on Tuesday, reaching $121.15. The stock had a trading volume of 340,572 shares, compared to its average volume of 1,845,448. The firm has a market cap of $34.54 billion, a PE ratio of 27.86, a P/E/G ratio of 3.39 and a beta of 1.11. The firm has a 50 day simple moving average of $136.34 and a 200-day simple moving average of $137.16. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.82%. Agilent Technologies's dividend payout ratio (DPR) is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.